Covalon's products take on the world's biggest healthcare challenges.
Advanced Wound Care
Covalon’s Advanced Wound Care line has been specially designed for the successful treatment of a wide range of wounds. Whether it’s a child with an abrasion who benefits from the pain reducing properties of a soft silicone adhesive, or a diabetic with a complex chronic wound that requires a state-of-the-art biomatrix dressing, Covalon’s CovaWound™ and ColActive® brands can help. Covalon offers a complete range of effective, user-friendly, cost beneficial advanced wound care products.
The ColActive® brand of Bio-Matrix dressings have been successfully healing chronic wounds, and in some cases preventing the need for limb amputation for almost 10 years. With ever increasing use in the U.S., ColActive® is now expanding into countries that have higher than average levels of diabetes, a condition often associated with chronic wounds. ColActive® is becoming the cost-effective, chronic wound dressing of choice for surgeons, dermatologists and podiatrists worldwide. Patients from around the world who suffer from diabetic foot, venous leg and pressure ulcers, are now benefitting from the patented formulation of the ColActive® brand.
Covalon’s advanced wound solutions are designed to remove the obstacles to healing, these include bioburden, exudate, and MMP inhibition.
As an invaluable component of modern medicine, up to 80% of patients admitted in the US receive some form of infusion therapy . For patients receiving long term access, Catheter Related Bloodstream Infections (CRBSIs) can be a devastating and costly complication. In the US alone, it has been estimated that each year, 80,000 CRBSIs occur in ICU patients, costing approximately $2.3 billion to the US healthcare system . In addition, Medical Adhesive-Related Skin Injuries caused by recurring dressing changes continue to impact patients and can result in pain, delayed healing, and increased healthcare costs .
To address this problem, Covalon Technologies Ltd. has developed an innovative vascular access dressing that offers unparalleled infection prevention without sacrificing patient comfort. IV Clear incorporates dual antimicrobial action into a soft silicone adhesive, killing 99.99% of microorganisms commonly associated with CRBSIs and preventing regrowth for up to 7 days . No longer are clinicians required to compromise comfort over efficacy when choosing a product that fits within a hospital’s infection prevention bundle.
ONE MOTHER OF A CHILD WHO HAS A LONG-TERM CENTRAL VENOUS CATHETER SAID OF IV CLEAR™:
“Now that we’ve found IV Clear™, our son is no longer afraid of dressing changes. The skin around his catheter site is beautiful and healthy, easily visible through the dressing, and we no longer have to worry about missing a site infection or the fact that his dressing required frequent changes because it wasn’t lasting a full week. Thanks to IV Clear™, instead of worrying about his line, he is able to spend more of his time doing things typical kids do.”
In addition to IV Clear™, Covalon’s vascular access portfolio includes CovaView™ IV, a transparent film dressing that provides an effective barrier against external contaminants including fluid, bacteria, and yeast.
Perioperative care refers to the three phases of surgery: preoperative, intraoperative, and postoperative care. Its goal as it relates to the patient’s skin that is to be incised is to provide optimal conditions before, during, and after the operation, because whether a surgical procedure is minimally invasive or highly involved, one constant remains, the patient’s skin will be compromised.
Now, and for the first time ever, nurses, surgeons and patients have access to a comprehensive approach to perioperative skin protection and care. Covalon’s Perioperative Care brands, MediClear™ and SurgiClear™ offer a continuum of care throughout the patient’s surgical journey. From pre-procedural protection from the patient’s own skin bacteria [a leading cause of Surgical Site Infections (SSI)] through post op antimicrobial infection prevention and incision site visibility to finally reducing the severity of the incision scar, Covalon’s products can help.
ONE PERIOPERATIVE NURSE FROM A U.S. HOSPITAL STATED:
“We continue to maximize using the dressings (SurgiClear), not just on sternal incisions, but now also all thoracotomy incisions, vein harvest incisions (if there is a large incision), and CT site incisions. My surgeons are very happy with the reduced number of infections we have seen over the last year.”
Covalon’s perioperative care brands follow the patient through their surgical journey with a seamless combination of products that bring unparalleled patient compliance, unmatched comfort, and undeniable protection.
Contact Covalon today to learn more about how you can benefit from the innovations within its Perioperative Skin Care Brands.
1. KELEEKAI ET AL. IMPROVING NURSES’ PERIPHERAL INTRAVENOUS CATHETER INSERTION KNOWLEDGE, CONFIDENCE, AND SKILLS USING A SIMULATION-BASED BLENDED LEARNING PROGRAM. SIM HEALTHCARE 11:376–384, 2016.
2. PRONOVOST ET AL. AN INTERVENTION TO DECREASE CATHETER-RELATED BLOODSTREAM INFECTIONS IN THE ICU. N ENGL J MED 355;26: 2725-2732, 2006.
3. CUTTING, K.F. IMPACT OF ADHESIVE SURGICAL TAPE AND WOUND DRESSINGS ON THE SKIN, WITH REFERENCE TO SKIN STRIPPING. J WOUND CARE 17;4: 157-162, 2008.
4. COVALON DATA ON FILE.
5. TIMSIT ET AL. DRESSING DISRUPTION IS A MAJOR RISK FACTOR FOR CATHETER-RELATED INFECTIONS. CRIT. CARE MED. 40;6: 1707-1714, 2012.